RecruitingNCT06513091
US National TOP Registry
US National OCS Lung Thoracic Organ Perfusion (TOP) Registry
Sponsor
TransMedics
Enrollment
10,000 participants
Start Date
Jan 23, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
Eligibility
Inclusion Criteria1
- All lung transplant recipients
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEOCS Lung
The TransMedics Organ Care System (OCS) Lung is an FDA approved portable extracorporeal lung perfusion and monitoring system.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06513091
Related Trials
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
NCT055476983 locations
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
NCT0647613212 locations
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates
NCT054262003 locations
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
NCT067700231 location
Tocilizumab in Lung Transplantation
NCT0603319621 locations